| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $678K | +0.0% |
| R&D Expense | $294K | +0.0% |
| SG&A Expense | $96K | -27.6% |
| Operating Income | -$2.7M | -1335.3% |
| Net Income | -$6.4M | -242.0% |
| EPS (Basic) | -$1.90 | — |
| EPS (Diluted) | -$1.90 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3K | — |
| Current Assets | $3K | — |
| Total Assets | $11.0M | +52.7% |
| Current Liabilities | $2.2M | +53.5% |
| Total Liabilities | $3.2M | +27.9% |
| Stockholders' Equity | $7.8M | +65.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $517K | +55.9% |
| Capital Expenditures | $423K | — |
| Investing Cash Flow | -$506K | — |
| Financing Cash Flow | -$8K | +97.5% |
| Free Cash Flow | $93K | -71.8% |